1249781-69-8

Basic information

• Product Name: 6-ethoxy-5-Methylpyridin-3-aMine
• Synonyms: 6-ethoxy-5-Methylpyridin-3-aMine
• CAS NO: 1249781-69-8
• Molecular Formula: C8H12N2O
• Molecular Weight: 152.19368
• Mol File: 1249781-69-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 6-ethoxy-5-Methylpyridin-3-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-ethoxy-5-Methylpyridin-3-aMine(1249781-69-8)
• EPA Substance Registry System: 6-ethoxy-5-Methylpyridin-3-aMine(1249781-69-8)

Safety Data

• Hazardous Substances Data: 1249781-69-8(Hazardous Substances Data)

Usage

General Description

6-Ethoxy-5-methylpyridin-3-amine is a chemical compound with the molecular formula C8H11NO. It is a derivative of pyridine, a six-membered ring structure containing five carbon atoms and one nitrogen atom. The compound contains an ethoxy group (C2H5O) and a methyl group (CH3) attached to the pyridine ring. This chemical is commonly used in the synthesis of pharmaceuticals and agrochemicals. Its properties and applications make it a valuable intermediate in the production of various drugs and agricultural products.

Relevant articles and documents

NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF

An object of the present invention is to provide to a compound and a pharmaceutical composition, which have excellent Syk-inhibitory activity. Th e present invention provides a nicotinamide derivative represented by the follo wing formula (I) (wherein R 1 represents a halogen atom; R 2 represents a C 1-12 alkyl group, a C 2-12 alkenyl group, a C 2-12 alkynyl group, a C 3-8 cycloalkyl g roup, an aryl group, an ar-C 1-6 alkyl group or a heterocyclic group, each opti onally having at least one substituent; R 3 represents an aryl group or a hetero cyclic group each optionally having at least one substituent; and R 4 and R 5 e ach independently represent a hydrogen atom; and R 2 and R 4 may form a cyc lic amino group optionally having at least one substituent together with the ni trogen atom to which they bind) or a salt thereof, and a pharmaceutical comp osition for use in the treatment of a Syk-related disease which comprises the nicotinamide derivative or a salt thereof.